Clinical Trial Update: Safety and Efficacy of Celecoxib Plus Nucleos(t)Ide Analogues on the Hepatitis B Surface Antigen of Virally Suppressed Subjects With Chronic Hepatitis B [Phase 2]

View source ↗

Summary

Phase 2 trial updating safety and efficacy of combining celecoxib with nucleos(t)ide analogues in nucleoside-treated chronic hepatitis B patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Celecoxib (Celecoxib)
• nucleos(t)ide analogues

Snippet

Sponsor: Lai Wei | Conditions: To Evaluate the Safety and Efficacy of Celecoxib Plus Nucleos(t)Ide Analogues in Nucleos(t)Ide-treated Patients With Chronic Hepatitis B | Phase 2 | Status: UNKNOWN